Literature DB >> 21648198

Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.

Sibel Bozdağ-Pehlivan1, Birsel Subaşi, Imran Vural, Nurşen Unlü, Yilmaz Capan.   

Abstract

In the present study, the possible interactions between celecoxib and some excipients (colloidal silicon dioxide (Aerosil), microcrystalline cellulose (Avicel PH 102), lactose anhydrous, magnesium stearate, cross-povidone and talc) were evaluated by examining the pure drug or drug-excipient powder mixtures which were stored under different conditions (25 +/- 2 degrees C, 60% RH +/- 5% RH or 40 + 2 degrees C, 75% RH +/- 5% RH) and different period (30 or 60 days) using DSC, FT-IR and HPLC. In order to investigate the possibility of celecoxib-excipient interaction in aqueous medium, dispersions of the pure drug or drug in physical powder mixture (1:1 w/w) in water (1%, w/v) were also prepared and evaluated by FT-IR and HPLC at day 0 and day 7 (40 +/- 2 degrees C). The interaction between celecoxib and magnesium stearate or colloidal silicon dioxide were determined in the aqueous dispersions by FT-IR. Different tablet formulations with or without excipients tested were prepared, and assessed for drug dissolution and permeability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21648198

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  5 in total

1.  Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853).

Authors:  Arshi Naqvi; Anuja Pandey; Varsha Gupta; Richa Malasoni; Akansha Srivastava; Rishi Ranjan Pandey; M Satyanarayana; Ram Pratap; Anil Kumar Dwivedi
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

2.  Development of press-coated, floating-pulsatile drug delivery of lisinopril.

Authors:  Swati C Jagdale; Vishnu M Suryawanshi; Sudhir V Pandya; Bhanudas S Kuchekar; Aniruddha R Chabukswar
Journal:  Sci Pharm       Date:  2014-04-14

3.  Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.

Authors:  Shweta Gupta; Rajesh Kesarla; Narendra Chotai; Ambikanandan Misra; Abdelwahab Omri
Journal:  Biomed Res Int       Date:  2017-01-23       Impact factor: 3.411

4.  Thermal Stability and Kinetic Study of Fluvoxamine Stability in Binary Samples with Lactose.

Authors:  Faranak Ghaderi; Mahboob Nemati; Mohammad Reza Siahi-Shadbad; Hadi Valizadeh; Farnaz Monajjemzadeh
Journal:  Adv Pharm Bull       Date:  2017-04-13

5.  Stability indicating studies on NMITLI 118RT+ (standardized extract of withania somnifera dunal).

Authors:  Hafsa Ahmad; Kiran Khandelwal; Shakti Deep Pachauri; Rajender Singh Sanghwan; Anil Kumar Dwivedi
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.